Urgiso
Brand Name: Urgiso
Generic Name: Solifenacin Succinate
Active
Registration Number
DR-XY47877
Dosage Form
Film-Coated Tablet
Issuance Date
April 1, 2022
Expiry Date
April 1, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength5 mg
PackagingAlu/PVC Blister Pack by 10's (Box of 30's)
FDA
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Selective M3 Antimuscarinic Receptor Antagonist
A
Application
Initial
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Solifenacin SuccinateActive
Monograph: Solifenacin